A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-20
DOI
10.3389/fimmu.2021.638814
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker
- (2021) Iva Sorić Hosman et al. Frontiers in Immunology
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1
- (2020) Sara Abouelasrar Salama et al. Frontiers in Immunology
- Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity
- (2020) Ursula Smole et al. NATURE IMMUNOLOGY
- Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
- (2020) June-Yong Lee et al. CELL
- The turning away of serum amyloid A biological activities and receptor usage
- (2020) Sara Abouelasrar Salama et al. IMMUNOLOGY
- Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
- (2019) Elizabeth M A Hensor et al. RHEUMATOLOGY
- Serum Amyloid A Protein as a Potential Biomarker for Severity and Acute Outcome in Traumatic Brain Injury
- (2019) Evan Wicker et al. Biomed Research International
- Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: analysis of the ESPOIR cohort
- (2019) Chloé Bernardy et al. JOINT BONE SPINE
- Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime?
- (2019) Irene Di Ceglie et al. RHEUMATOLOGY
- Time to modify the DAS28 to make it fit for purpose(s) in rheumatoid arthritis?
- (2019) Elizabeth M. A. Hensor et al. Expert Review of Clinical Immunology
- Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis
- (2019) Gwenaël Nys et al. TALANTA
- Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection
- (2019) Sara Abouelasrar Salama et al. CYTOKINE & GROWTH FACTOR REVIEWS
- S100A8/A9 in Inflammation
- (2018) Siwen Wang et al. Frontiers in Immunology
- Bacterial Lipoproteins Constitute the TLR2-Stimulating Activity of Serum Amyloid A
- (2018) Edward J. Burgess et al. JOURNAL OF IMMUNOLOGY
- Diagnosis and Management of Rheumatoid Arthritis
- (2018) Daniel Aletaha et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Update of French society for rheumatology recommendations for managing rheumatoid arthritis
- (2018) Claire Daien et al. JOINT BONE SPINE
- Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis
- (2017) Hilde Haugedal Nordal et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
- (2016) Mieke Buck et al. CURRENT MEDICINAL CHEMISTRY
- Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate
- (2016) P. S. Patro et al. JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
- (2016) J. van den Hoek et al. RHEUMATOLOGY INTERNATIONAL
- Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab
- (2016) HH Nordal et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays
- (2015) Yeoun Jin Kim et al. PROTEOMICS
- Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis
- (2014) CHEN SHEN et al. Molecular Medicine Reports
- Influence of long-term leflunomide treatment on serum amyloid concentration in rheumatoid arthritis patients
- (2014) Bożena Targońska-Stępniak et al. Pharmacological Reports
- S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis
- (2014) Kwi Young Kang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
- (2013) Ivy Y Choi et al. ANNALS OF THE RHEUMATIC DISEASES
- Calprotectin in Rheumatoid Arthritis
- (2013) Miriam García-Arias et al. Molecular Diagnosis & Therapy
- The use of fecal calprotectin as a biomarker in gastrointestinal disease
- (2013) Emanuel Burri et al. Expert Review of Gastroenterology & Hepatology
- Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors
- (2013) Karin Christenson et al. Frontiers in Immunology
- The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation
- (2010) Lena Björkman et al. ARTHRITIS AND RHEUMATISM
- Long-term impact of delay in assessment of patients with early arthritis
- (2010) Michael P. M. van der Linden et al. ARTHRITIS AND RHEUMATISM
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage
- (2009) D Foell et al. GUT
- Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis
- (2008) H B. Hammer et al. ANNALS OF THE RHEUMATIC DISEASES
- Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis
- (2008) D. de Seny et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search